Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD). It contains an inhaled corticosteroid called ...

Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

In the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera (mometasone-formoterol). Under the SMART guidelines, these inhalers are used as both maintenance ...

Both inhalers were prepared in two different strengths, one delivering ex-valve 50µg of BDP/actuation, and another delivering 100 µg/actuation. Placebo formulations were also prepared for both ...